QBFM
SLXP

QS Batterymarch Financial Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

QS Batterymarch Financial Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$180K Sell
1,150
-6,820
-86% -$989K ﹤0.01% 692
2014
Q2 		$984K Sell
7,970
-18,950
-70% -$2.09M 0.02% 533
2014
Q1 		$2.79M Buy
26,920
+12,100
+82% +$1.24M 0.06% 426
2013
Q4 		$1.33M Hold
14,820
– – 0.03% 575
2013
Q3 		$992K Buy
+14,820
New +$1.02M 0.02% 626

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

QS Batterymarch Financial Management's SLXP Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its SALIX PHARMACEUTICALS LTD DEL (SLXP) stake by 86% in Q3 2014, selling an estimated $989K and leaving 1,150 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

QS Batterymarch Financial Management first reported a position in SLXP in Q3 2013 and has held it in 5 quarters since. The position peaked at $2.79M in Q1 2014. 348 funds tracked by Wall St. Rank hold SLXP as of Q3 2014.

  • QS Batterymarch Financial Management held 1,150 shares of SALIX PHARMACEUTICALS LTD DEL worth $180K as of Q3 2014.
  • QS Batterymarch Financial Management sold 6,820 SALIX PHARMACEUTICALS LTD DEL shares in Q3 2014, an estimated $989K.
  • SALIX PHARMACEUTICALS LTD DEL made up ﹤0.01% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #692 holding.
  • QS Batterymarch Financial Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and has held it in 5 quarters since.
  • QS Batterymarch Financial Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.79M in Q1 2014.
  • 348 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.